* Zevra Therapeutics, Inc. press release [https://seekingalpha.com/pr/20198646-zevra-reports-second-quarter-2025-financial-results-and-corporate-update] (NASDAQ:ZVRA [https://seekingalpha.com/symbol/ZVRA]): Q2 Non-GAAP EPS of -$0.06 misses by $1.44.
* Revenue of $25.88M (+481.6% Y/Y) beats by $3.39M.
MORE ON ZEVRA THERAPEUTICS, INC.
* Zevra Therapeutics Q2 2025 Earnings Preview [https://seekingalpha.com/news/4483286-zevra-therapeutics-q2-2025-earnings-preview]
* Seeking Alpha’s Quant Rating on Zevra Therapeutics, Inc. [https://seekingalpha.com/symbol/ZVRA/ratings/quant-ratings]
* Historical earnings data for Zevra Therapeutics, Inc. [https://seekingalpha.com/symbol/ZVRA/earnings]
* Financial information for Zevra Therapeutics, Inc. [https://seekingalpha.com/symbol/ZVRA/income-statement]
Zevra Therapeutics, Inc. Non-GAAP EPS of -$0.06 misses by $1.44, revenue of $25.88M beats by $3.39M
Published 2 months ago
Aug 12, 2025 at 8:10 PM
Positive
Auto